Remedium Lifecare Intrinsic Value
REMLIFE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.43 | ₹1.94 - ₹2.92 | +200.0% | EPS: ₹0.40, Sector P/E: 12x |
| Book Value Method | asset | ₹2.03 | ₹1.83 - ₹2.23 | +150.6% | Book Value/Share: ₹11.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.62 | ₹1.46 - ₹1.78 | +100.0% | Revenue/Share: ₹114.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1.62 | ₹1.46 - ₹1.78 | +100.0% | EBITDA: ₹44.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹2.43 | ₹2.19 - ₹2.67 | +200.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹2.43 | ₹2.19 - ₹2.67 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1.62 | ₹1.46 - ₹1.78 | +100.0% | ROE: 81.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2.43 | ₹2.19 - ₹2.67 | +200.0% | EPS: ₹0.40, BVPS: ₹11.00 |
Want to compare with current market value? Check REMLIFE share price latest .
Valuation Comparison Chart
REMLIFE Intrinsic Value Analysis
What is the intrinsic value of REMLIFE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Remedium Lifecare (REMLIFE) is ₹2.43 (median value). With the current market price of ₹0.81, this represents a +200.0% variance from our estimated fair value.
The valuation range spans from ₹1.62 to ₹2.43, indicating ₹1.62 - ₹2.43.
Is REMLIFE undervalued or overvalued?
Based on our multi-method analysis, Remedium Lifecare (REMLIFE) appears to be trading below calculated value by approximately 200.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 39.09 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 81.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.27x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Remedium Lifecare
Additional stock information and data for REMLIFE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1,135 Cr | ₹-1,135 Cr | Negative Cash Flow | 3/10 |